1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DNA And RNA Synthesis Equipment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for DNA And RNA Synthesis Equipment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for DNA And RNA Synthesis Equipment by Country/Region, 2018, 2022 & 2029
2.2 DNA And RNA Synthesis Equipment Segment by Type
2.2.1 12 Channels
2.2.2 192 Channels
2.2.3 768 Channels
2.3 DNA And RNA Synthesis Equipment Sales by Type
2.3.1 Global DNA And RNA Synthesis Equipment Sales Market Share by Type (2018-2023)
2.3.2 Global DNA And RNA Synthesis Equipment Revenue and Market Share by Type (2018-2023)
2.3.3 Global DNA And RNA Synthesis Equipment Sale Price by Type (2018-2023)
2.4 DNA And RNA Synthesis Equipment Segment by Application
2.4.1 Academic Institution
2.4.2 Research Center
2.4.3 Pharmaceutical Company
2.4.4 Others
2.5 DNA And RNA Synthesis Equipment Sales by Application
2.5.1 Global DNA And RNA Synthesis Equipment Sale Market Share by Application (2018-2023)
2.5.2 Global DNA And RNA Synthesis Equipment Revenue and Market Share by Application (2018-2023)
2.5.3 Global DNA And RNA Synthesis Equipment Sale Price by Application (2018-2023)
3 Global DNA And RNA Synthesis Equipment by Company
3.1 Global DNA And RNA Synthesis Equipment Breakdown Data by Company
3.1.1 Global DNA And RNA Synthesis Equipment Annual Sales by Company (2018-2023)
3.1.2 Global DNA And RNA Synthesis Equipment Sales Market Share by Company (2018-2023)
3.2 Global DNA And RNA Synthesis Equipment Annual Revenue by Company (2018-2023)
3.2.1 Global DNA And RNA Synthesis Equipment Revenue by Company (2018-2023)
3.2.2 Global DNA And RNA Synthesis Equipment Revenue Market Share by Company (2018-2023)
3.3 Global DNA And RNA Synthesis Equipment Sale Price by Company
3.4 Key Manufacturers DNA And RNA Synthesis Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DNA And RNA Synthesis Equipment Product Location Distribution
3.4.2 Players DNA And RNA Synthesis Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for DNA And RNA Synthesis Equipment by Geographic Region
4.1 World Historic DNA And RNA Synthesis Equipment Market Size by Geographic Region (2018-2023)
4.1.1 Global DNA And RNA Synthesis Equipment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global DNA And RNA Synthesis Equipment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic DNA And RNA Synthesis Equipment Market Size by Country/Region (2018-2023)
4.2.1 Global DNA And RNA Synthesis Equipment Annual Sales by Country/Region (2018-2023)
4.2.2 Global DNA And RNA Synthesis Equipment Annual Revenue by Country/Region (2018-2023)
4.3 Americas DNA And RNA Synthesis Equipment Sales Growth
4.4 APAC DNA And RNA Synthesis Equipment Sales Growth
4.5 Europe DNA And RNA Synthesis Equipment Sales Growth
4.6 Middle East & Africa DNA And RNA Synthesis Equipment Sales Growth
5 Americas
5.1 Americas DNA And RNA Synthesis Equipment Sales by Country
5.1.1 Americas DNA And RNA Synthesis Equipment Sales by Country (2018-2023)
5.1.2 Americas DNA And RNA Synthesis Equipment Revenue by Country (2018-2023)
5.2 Americas DNA And RNA Synthesis Equipment Sales by Type
5.3 Americas DNA And RNA Synthesis Equipment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA And RNA Synthesis Equipment Sales by Region
6.1.1 APAC DNA And RNA Synthesis Equipment Sales by Region (2018-2023)
6.1.2 APAC DNA And RNA Synthesis Equipment Revenue by Region (2018-2023)
6.2 APAC DNA And RNA Synthesis Equipment Sales by Type
6.3 APAC DNA And RNA Synthesis Equipment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe DNA And RNA Synthesis Equipment by Country
7.1.1 Europe DNA And RNA Synthesis Equipment Sales by Country (2018-2023)
7.1.2 Europe DNA And RNA Synthesis Equipment Revenue by Country (2018-2023)
7.2 Europe DNA And RNA Synthesis Equipment Sales by Type
7.3 Europe DNA And RNA Synthesis Equipment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DNA And RNA Synthesis Equipment by Country
8.1.1 Middle East & Africa DNA And RNA Synthesis Equipment Sales by Country (2018-2023)
8.1.2 Middle East & Africa DNA And RNA Synthesis Equipment Revenue by Country (2018-2023)
8.2 Middle East & Africa DNA And RNA Synthesis Equipment Sales by Type
8.3 Middle East & Africa DNA And RNA Synthesis Equipment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DNA And RNA Synthesis Equipment
10.3 Manufacturing Process Analysis of DNA And RNA Synthesis Equipment
10.4 Industry Chain Structure of DNA And RNA Synthesis Equipment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DNA And RNA Synthesis Equipment Distributors
11.3 DNA And RNA Synthesis Equipment Customer
12 World Forecast Review for DNA And RNA Synthesis Equipment by Geographic Region
12.1 Global DNA And RNA Synthesis Equipment Market Size Forecast by Region
12.1.1 Global DNA And RNA Synthesis Equipment Forecast by Region (2024-2029)
12.1.2 Global DNA And RNA Synthesis Equipment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global DNA And RNA Synthesis Equipment Forecast by Type
12.7 Global DNA And RNA Synthesis Equipment Forecast by Application
13 Key Players Analysis
13.1 Beckman Coulter
13.1.1 Beckman Coulter Company Information
13.1.2 Beckman Coulter DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.1.3 Beckman Coulter DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Beckman Coulter Main Business Overview
13.1.5 Beckman Coulter Latest Developments
13.2 ACTGene
13.2.1 ACTGene Company Information
13.2.2 ACTGene DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.2.3 ACTGene DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ACTGene Main Business Overview
13.2.5 ACTGene Latest Developments
13.3 Precision System Science
13.3.1 Precision System Science Company Information
13.3.2 Precision System Science DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.3.3 Precision System Science DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Precision System Science Main Business Overview
13.3.5 Precision System Science Latest Developments
13.4 CSBio
13.4.1 CSBio Company Information
13.4.2 CSBio DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.4.3 CSBio DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CSBio Main Business Overview
13.4.5 CSBio Latest Developments
13.5 Genscript Biotech
13.5.1 Genscript Biotech Company Information
13.5.2 Genscript Biotech DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.5.3 Genscript Biotech DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Genscript Biotech Main Business Overview
13.5.5 Genscript Biotech Latest Developments
13.6 Protein Technologies
13.6.1 Protein Technologies Company Information
13.6.2 Protein Technologies DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.6.3 Protein Technologies DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Protein Technologies Main Business Overview
13.6.5 Protein Technologies Latest Developments
13.7 Applied Biosystems
13.7.1 Applied Biosystems Company Information
13.7.2 Applied Biosystems DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.7.3 Applied Biosystems DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Applied Biosystems Main Business Overview
13.7.5 Applied Biosystems Latest Developments
13.8 K&A Labs GmbH
13.8.1 K&A Labs GmbH Company Information
13.8.2 K&A Labs GmbH DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.8.3 K&A Labs GmbH DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 K&A Labs GmbH Main Business Overview
13.8.5 K&A Labs GmbH Latest Developments
13.9 General Electric
13.9.1 General Electric Company Information
13.9.2 General Electric DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.9.3 General Electric DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 General Electric Main Business Overview
13.9.5 General Electric Latest Developments
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Information
13.10.2 Thermo Fisher Scientific DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.10.3 Thermo Fisher Scientific DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Thermo Fisher Scientific Main Business Overview
13.10.5 Thermo Fisher Scientific Latest Developments
13.11 Tekna Plasma Systems
13.11.1 Tekna Plasma Systems Company Information
13.11.2 Tekna Plasma Systems DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.11.3 Tekna Plasma Systems DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tekna Plasma Systems Main Business Overview
13.11.5 Tekna Plasma Systems Latest Developments
13.12 BioAutomation Corporation
13.12.1 BioAutomation Corporation Company Information
13.12.2 BioAutomation Corporation DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.12.3 BioAutomation Corporation DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BioAutomation Corporation Main Business Overview
13.12.5 BioAutomation Corporation Latest Developments
13.13 Polygen GmbH
13.13.1 Polygen GmbH Company Information
13.13.2 Polygen GmbH DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.13.3 Polygen GmbH DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Polygen GmbH Main Business Overview
13.13.5 Polygen GmbH Latest Developments
13.14 GlobalSpec
13.14.1 GlobalSpec Company Information
13.14.2 GlobalSpec DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.14.3 GlobalSpec DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 GlobalSpec Main Business Overview
13.14.5 GlobalSpec Latest Developments
13.15 Biolytic Lab Performance
13.15.1 Biolytic Lab Performance Company Information
13.15.2 Biolytic Lab Performance DNA And RNA Synthesis Equipment Product Portfolios and Specifications
13.15.3 Biolytic Lab Performance DNA And RNA Synthesis Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Biolytic Lab Performance Main Business Overview
13.15.5 Biolytic Lab Performance Latest Developments
14 Research Findings and Conclusion
| ※参考情報 DNA・RNA合成装置は、ナノスケールの分子を合成するための高度な技術機器であり、主に遺伝子工学、バイオテクノロジー、医学、及び基礎科学の研究において重要な役割を果たしています。これらの装置は、合成したいDNAまたはRNAの塩基配列に基づいて、核酸を精密に生成することができるため、さまざまな用途に応じて利用されています。 まず、DNA・RNA合成装置の基本的な定義について説明します。DNA合成は、指定された核酸の配列に従って核酸鎖を構築する過程であり、RNA合成も同様に行われます。これらの合成は、化学的なプロセスを利用して行われ、特に短いオリゴヌクレオチドの合成においては、自動化された装置が広く用いられています。DNAやRNAの合成は、一般的に「固相合成」と呼ばれる手法を用いて行われます。このプロセスでは、初期のヌクレオチドが固体基盤に固定され、その上に次のヌクレオチドが段階的に追加されていきます。 次に、DNA・RNA合成装置の特徴について触れます。これらの装置は高度に自動化されていることが多く、オペレーターは合成したい配列を入力することで、選択したプロトコルに基づいて合成が開始されます。多くの装置は、反応の温度管理や化学薬品の投与を自動化しており、効率的かつ正確な合成を実現しています。また、反応過程の監視やデータ記録が容易であり、結果のトレーサビリティが確保されています。 種類としては、主に2つのカテゴリが存在します。第一に、DNA合成装置があります。これは、特それぞれのヌクレオチドの順序に基づいてDNA鎖を合成します。この装置は、実験室で行われるクローン化や遺伝子編集、PCR（ポリメラーゼ連鎖反応）などの前処理に使用されます。第二に、RNA合成装置があります。RNA合成には、mRNA合成やsiRNA、miRNAなどを目的とした合成が含まれ、自らの遺伝子発現を調整するためのツールとして広く利用されています。 用途としては、学術研究や医療の分野にわたります。例えば、医学研究では疾病のメカニズムの解明や遺伝子治療の開発に向けた基盤技術として重要です。合成したDNAやRNAは、遺伝子の発現を調べるためのプローブや、特定のタンパク質を生成するためのテンプレートとして使用されます。また、合成オリゴヌクレオチドは、ワクチン開発や診断技術においても重要な役割を果たしています。 関連技術としては、次世代シーケンシング（NGS）やCRISPR-Cas9などがあります。NGSは遺伝子の配列を迅速に解析する技術であり、DNA・RNA合成装置と組み合わせることで、より精密な遺伝子的解析が可能となります。また、CRISPR-Cas9技術は遺伝子編集を行うための手段として知られており、合成したRNAをガイドRNAとして利用することで、特定の遺伝子をターゲティングすることができます。このように、DNA・RNA合成装置は多くの先端技術と連携しながら、遺伝子研究に貢献しています。 最後に、最近の進展についても言及します。近年では、合成技術の進化により、より長大で複雑なDNAやRNAの合成が可能となっています。また、新しい合成方法や材料の開発も進んでおり、合成速度やコスト効率が向上しています。これにより、バイオテクノロジー関連の研究は一層加速し、医療や環境問題の解決に向けた新たなソリューションを提供することが期待されています。 DNA・RNA合成装置は、分子生物学の基礎技術として、研究者たちの手により、様々な分野での突破口を切り開いています。今後もこの技術は進化を続け、私たちの理解を深め、新しい治療法の開発に貢献することでしょう。科学の最前線を支える役割を果たしているこれらの装置は、今後の研究においても重要な存在であり続けることが確実であると言えます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
